| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003248347 |
| P356 | DOI | 10.1007/S00296-016-3426-2 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s00296-016-3426-2 |
| P698 | PubMed publication ID | 26803313 |
| P50 | author | Johan Trygg | Q88000623 |
| P2093 | author name string | Roald Omdal | |
| Grete Jonsson | |||
| Torbjörn Lundstedt | |||
| Izabella Surowiec | |||
| Katrine Brække Norheim | |||
| Clara Gram Gjesdal | |||
| P2860 | cites work | The prevalence and meaning of fatigue in rheumatic disease. | Q54349156 |
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis | Q61912544 | ||
| Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on e | Q63101754 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis | Q75221561 | ||
| Evidence for aerobic insufficiency in women with systemic Lupus erythematosus | Q78963038 | ||
| Isoprenoid pathway dysfunction in chronic fatigue syndrome | Q87472518 | ||
| MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis | Q24632755 | ||
| From inflammation to sickness and depression: when the immune system subjugates the brain | Q24633527 | ||
| Interleukin-1 inhibition and fatigue in primary Sjögren's syndrome--a double blind, randomised clinical trial | Q28478765 | ||
| Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models | Q31137205 | ||
| The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS. | Q33220323 | ||
| Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis | Q33699851 | ||
| Biological basis of the behavior of sick animals | Q34048744 | ||
| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q34130671 | ||
| TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. | Q34180844 | ||
| Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms | Q34441002 | ||
| Fatigue in primary Sjögren's syndrome--a link to sickness behaviour in animals? | Q34989420 | ||
| Diagnostic properties of metabolic perturbations in rheumatoid arthritis | Q35620317 | ||
| Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS | Q36208046 | ||
| Oxidative stress and arachidonic acid mobilization. | Q36465008 | ||
| Metabolic profiling predicts response to anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis | Q37023883 | ||
| Oxidative stress in fibromyalgia and its relationship to symptoms | Q37124549 | ||
| The impact of inflammation on metabolomic profiles in patients with arthritis | Q37343272 | ||
| Antimicrobial mechanisms of phagocytes and bacterial evasion strategies | Q37445493 | ||
| Biological mechanisms of chronic fatigue | Q37834153 | ||
| Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. | Q37936500 | ||
| Oxidative stress and fatigue in systemic lupus erythematosus | Q38003125 | ||
| Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence | Q38096125 | ||
| Fatigue in Newly Diagnosed Inflammatory Bowel Disease | Q41726168 | ||
| (1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis | Q42572005 | ||
| Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. | Q42789574 | ||
| 1H NMR spectroscopy-based interventional metabolic phenotyping: a cohort study of rheumatoid arthritis patients. | Q42940729 | ||
| Status of oxidative stress in rheumatoid arthritis | Q43107164 | ||
| Metabolic responses to change in disease activity during tumor necrosis factor inhibition in patients with rheumatoid arthritis | Q45733308 | ||
| Extraction and GC/MS analysis of the human blood plasma metabolome | Q46849028 | ||
| Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus | Q46879415 | ||
| NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome | Q48236988 | ||
| Urinary and plasma organic acids and amino acids in chronic fatigue syndrome. | Q51514499 | ||
| Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. | Q53196713 | ||
| Scleroderma | Q54165664 | ||
| P433 | issue | 5 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| metabolomics | Q12149006 | ||
| P304 | page(s) | 703-711 | |
| P577 | publication date | 2016-01-23 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment | |
| P478 | volume | 36 |
| Q40697506 | Conventional treatment regimens for ulcerative colitis alleviate fatigue - an observational cohort study |
| Q39225796 | Fatigue in Rheumatoid Arthritis |
| Q47973220 | Fatigue in psoriasis: a controlled study |
| Q39209693 | Immunometabolism in early and late stages of rheumatoid arthritis. |
| Q47181008 | Metabolomic markers of fatigue: Association between circulating metabolome and fatigue in women with chronic widespread pain |
Search more.